RedHill revenues up 31 percent in Q4

RedHill Biopharma's revenues continue to climb after starting U.S. promotional activities for two gastrointestinal products in June and September.  That's as the Tel-Aviv, Israel-based company continues to build up its U.S. commercial operations based in Raleigh. Net revenues were $2 million for the fourth quarter of 2017, up 31 percent over the third quarter, RedHill (Nasdaq: RDHL) reported Monday. The company stated that it “expects cont inued quarter over quarter net revenue growth.”  As…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news